Current issues
Table of contents: 2023
Clinical evidence has implicated advanced glycation end products (AGEs) as one of the risk factors for neurological dysfunction and death. However, the neurodegeneration regulation initiated by external AGEs has not yet been fully identified. We investigated the neuroprotective effect of Fimbristylis ovata extract, a medicinal plant utilized in Thai traditional medicine, against neuronal cell death in response to AGEs-induced cellular stress stimuli. SH-SY5Y, a human neuroblastoma cell, was used to investigate the relationship between AGEs induction and neuronal cell damage. The herbal extract derived from F. ovata, a member of the Cyperaceae family, was tested for its properties against AGEs-induced neuronal stress through changes in RAGE, Mn-SOD, p38 MAPK, and JNK protein expression. APP-related genes, including APP, ADAM10, BACE1, PSEN1, and TACE, were also tested. We found that F. ovata extract exerted its antioxidant activity by normalized AGEs-mediated RAGE elevation and increased Mn-SOD levels. Total apoptotic cells were also decreased by F. ovata extract treatment; this perhaps was due to its ability to suppress JNK activation. Additionally, reduction of expression of APP-related genes including APP, PSEN1, and TACE (or ADAM17) was observed in the F. ovata extract-treated groups. These results provide evidence that F. ovata extract has potential as a neuroprotective agent through its antioxidant and anti-apoptotic properties.
In recent years, the number of people with type 2 diabetes mellitus has increased rapidly and it has become an important public health problem in Vietnam. To provide valuable information on the efficacy and safety of diabetes medications (metformin and gliclazide), we evaluated how they affected the expression level and mutations of the SLC2A2 gene in the liver of T2DM patients. The SLC2A2 gene was analyzed in 165 patients with T2DM and 54 control subjects. Anthropometry, clinical parameters, molecular analysis, and gene expression were examined. We discovered high levels of mRNA SLC2A2 expression in the livers of people with T2DM who did not receive drug treatment. These levels were 1.5 times higher when compared to other groups that received drug treatment. Mutations of the SLC2A2 gene sequence were recorded in two T2DM patients belonging to the therapy group (c.1127T>G (p.Met376Arg) in exon 9 and c.609T>C (p.Ser203Ser) in exon 5). Finally, we found a strong and significant relationship between the glycemic control index and two enzymes, alanine aminotransferase and aspartate aminotransferase, with mRNA SLC2A2 expression under therapy. Our findings identified mutations of the SLC2A2 gene and a positive correlation between SLC2A2 gene expression and the effects of gliclazide and metformin in the liver of T2DM patients. This might contribute to a better understanding of the SLC2A2 gene, and the safety and tolerability of metformin and gliclazide therapy.
Ideal DNA extraction techniques must be efficient in terms of time, labor, and costs, optimizing yield and quality of the DNA for the desired applications. We tested six DNA extraction methods: DNeasy® Blood & Tissue Kit, Cetyltrimethylammonium bromide (CTAB), Modified salting-out protocol (SA), Boiling Tissue, Proteinase K (PK) and Mini Kit Applied Biosystems, on fin clippings from tambaqui (Colossoma macropomum). DNA yield, purity, quality, and cost of each method were evaluated. The effectiveness of extraction was evaluated by PCR amplification and genotyping efficiency, repeatability and accuracy. DNA yield and purity were quantified using NanoDrop absorbance ratios. Cost was estimated in terms of time and material expenses. The results showed differences between the tested methods, with the PK method having the best performance, followed by SA and CTAB. PK was identified as the most economical and efficient technique in terms of time, cost, and scalability/potential automation, while also generating DNA of good quality for performing PCR amplification and SNP genotyping with tambaqui samples.
Detection via PCR is a fast, sensitive, and highly specific method. However, the cost for testing through this technique is quite high, mainly because of the costs of the kits that are used. We looked for the best cost-effective alternative for Dengue virus (DENV) detection via PCR through the evaluation, optimization, and comparison of RT-PCR (Reverse Transcription - PCR) and RT-qPCR (Reverse Transcription–qPCR) detection kits. The biological material was samples of blood serum collected from 40 Brazilian patients suspected of DENV infection. Two reaction final volumes were tested for diagnosis via RT-PCR, 12.5 µL and 25 µL, and diagnosis via RT-qPCR was performed using the two-step approach with the Sybr Green detection system. An analysis of the associated cost for each approach was also made. Analysis via RT-PCR allowed viral RNA amplification from 27 samples, independent of the final reaction volume tested. Diagnosis via RT-qPCR enabled virus identification from 33 samples. The costs per reaction for the RT-PCR technique were US$ 2.91 and US$ 2.41 American dollars for the final reaction volumes of 25 µL and 12.5 µL, respectively. For the RT-qPCR technique, the reaction cost was found to be US$ 2.30. The comparison between the techniques showed that RT-qPCR was more sensitive, allowing virus detection in a larger number of samples. However, results indicated that RT-PCR (12.5 µL) can be used as a screening method, considering its lower reaction cost. The cost analysis showed that RT-qPCR had the best cost-benefit ratio, since it allowed virus detection from a larger number of samples with a cost similar to RT-PCR. We also found that optimization of the cDNA (complementary DNA) synthesis step can significantly affect the final diagnosis cost for both techniques.
The folate cycle is a biochemical pathway that plays an important role in the development and maintenance of the nervous system. Biocompounds synthesized in this cycle must be carefully regulated, since the accumulation of some substances can be neurotoxic and increase susceptibility to neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). The methylenetetrahydrofolate reductase (MTHFR), 5-methyltetrahydrofolate-homocysteine S-methyltransferase (MTR), and solute carrier family 19 member 1 (SLC19A1) genes encode important proteins for this regulation. In this systematic review and meta-analysis, we investigated the association of some polymorphisms in the MTHFR, MTR, and SLC19A1 genes and their associations with ALS and MS. The protocol of this systematic review is registered in the PROSPERO platform (CRD42021232352). We performed a search in EMBASE, Pubmed/NCBI, Scopus, Virtual Health Library (BVS), and Web of Science databases for studies that described polymorphisms in these genes, regardless of statistical association. Thirteen studies were included, and four polymorphisms were identified: C677T (rs1801133) and A1298C (rs1801131) in the MTHFR gene, A2756G (rs1805087) in the MTR gene, and A80G in the SLC19A1 gene. In the meta-analysis, the allelic and genotypic comparison for the C677T polymorphism showed a 1.5-fold increased risk for MS. Despite this significant result, we found a lack of association of most polymorphisms in the MTR, SLC19A1 and MTHFR genes and susceptibility for developing ALS and MS. Further studies are needed to clarify the role of polymorphisms in folate pathway genes in the susceptibility for developing these neurodegenerative diseases.
Amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) are degenerative scleroses with unclear etiology. Vascular endothelial growth factor A (VEGF-A) is a growth factor that plays multiple roles in the central nervous system. Previous studies indicated a potential association between polymorphisms in this gene and the susceptibility of ALS and MS; however, the results have been inconclusive. Here, we conducted a systematic review and meta-analysis to elucidate the relationship between polymorphisms in the VEGF-A gene and these degenerative scleroses. We searched for observational studies in PubMed, Web of Science, EMBASE, Virtual Health Library (BVS) and SCOPUS, without temporal and language restrictions and 12 studies were included in the systematic review. Six polymorphisms were identified: C-1558T, A-1190G, G-1154A (rs1570360), C-2578A (rs699947), C-634G (rs2010963), and C936T (rs3025039). After a systematic literature search, a pooled odds ratio (OR) and 95% confidence interval (CI) were used to evaluate the association of C-2578A, G-1154A, and G-634C polymorphisms and ALS. Due to the small number of articles found in this review for MS, it was not possible to perform a meta-analysis for this disease. The meta-analysis for ALS included 1441 patients and 1978 controls for C-2578A, and 1134 patients and 1629 controls for G-1154A and G-634C polymorphisms. No SNP was significantly associated with risk for ALS. We conclude that polymorphisms in the VEGF-A gene may not be a major risk factor for the development of ALS and MS; However, associated with specific factors, such as sex or haplotype combinations, they may become a strong susceptibility factor. Although we found a lack of association in most VEGF-A polymorphisms and the susceptibility for developing ALS and MS, this review provides a comprehensive understanding for the potential role of this gene in degenerative sclerosis.
The aggressiveness of fungal diseases in oats compromises grain yield. Although fungicides are effective for control, there is a need for productivity with food and environmental safety. Thus, we seek cultivars responsive to more sustainable management. The objective of this study was to identify oat cultivars that are more responsive to reduced fungicide use and a longer application-to-harvest interval with satisfactory yields, and to identify relevant variables in the simulation of grain yield by multiple linear regression. The study was carried out in 2019 and 2020 in Augusto Pestana, RS, a prominent region for oat cultivation in Brazil. The experimental design was randomized blocks, with three replications in a 22 x 4 factorial scheme, for 22 oat cultivars, recommended and no longer suitable for cultivation and four conditions of sequential use of fungicide (no application; one application 60 days after emergence; two applications, 60 and 75 days after emergence; and three applications, 60, 75 and 90 days after emergence). The fungicide used was FOLICUR® CE, at a dosage of 0.75 liters ha-1. The variables analyzed were necrotic leaf area and grain yield. The Stepwise technique was used to identify potential variables for the multiple linear regression model. The cultivars FAEM 4 Carlasul, URS Altiva, URS Charrua and URS Guará show superiority in grain yield in the absence of fungicide. In a single application, 60 days after emergence, FAEM 4 Carlasul and URS Charrua showed productivity above 3000 kg ha-1 with a long interval (around 60 days) from application to harvest. The variables minimum average temperature, necrotic leaf area and number of fungicide applications were found to be suitable for the composition of a multiple linear regression model to simulate grain yield.
Senecavirus A (SVA) is a nonenveloped, single-stranded RNA virusThe icosahedral viral particle is composed of four structural proteins: VP1, VP2, VP3 and VP4, among which VP2 is strongly involved in the antibody immune response. The virus causes vesicles on the snout and feet in pigs, which are clinically indistinguishable from other vesicular diseases such as foot-and-mouth disease. Outbreaks of SVA have been reported worldwide since 2014; however, its prevalence in Brazil remains unknown. In this study, the VP2 structural protein was produced and purified from E. coli, and recombinant VP2 (rVP2), based on the most recent Brazilian strain, was used to develop an indirect ELISA to identify antibodies against SVA in Brazilian swine herds. Sensitivity and specificity values of the rVP2 ELISA were determined using receiver operating characteristic analysis performed on 43 SVA positive and 219 negative serum samples. In addition, serum samples from pigs immunized with eight distinct Brazilian SVA inactivated strains were tested with the rVP2 ELISA. For the specificity of the assay, 17 serum samples from vesicular stomatitis virus (VSV) from naturally infected pigs were tested. The rVP2 ELISA was found to have 100% specificity and 74.4% sensitivity. The performance of the assay using samples collected during the SVA outbreak, had a sensitivity of 100%, and with those collected nine months after the outbreak it had a sensitivity of 73.4%. The rVP2 ELISA developed here was able to detect specific SVA antibodies in acute disease and recovered pigs, and no cross-reactivity with VSV was observed. This assay has potential as a useful tool for monitoring SVA infection and could help to improve disease diagnosis.
We evaluated methylenetetrahydrofolate reductase gene C677T polymorphisms in patients with colorectal cancer in a population-based case-control study in the Azerbaijan population. Genomic DNA was isolated from blood samples taken from 155 patients with colorectal cancer and 155 healthy individuals. The MTHFR gene C677T polymorphism was detected on agarose gel by PCR-RFLP. The frequencies of the CC, CT, and TT genotypes of MTHFR (C677T) were 54, 37, and 9% in the patients with colorectal cancer and 65, 29, and 6% in the healthy control, respectively. Heterozygote CT (OR = 1.422, 95%CI = 0.883–2.289, P = 0.147) and homozygous mutant TT (OR = 1.440, 95% CI = 0.619–3.348, P = 0.395) genotypes were more frequent in colorectal cancer patients compared to controls. No significant associations were observed between genotype and allele frequency of the MTHFR gene and the risk of colorectal cancer. Our findings suggested that MTHFR C677T polymorphism might not be associated with the overall risk of colorectal cancer in an Azerbaijani population. However, these conclusions need to be validated in a larger cohort study.
Valproic acid (VPA) is a drug that is often used to treat epilepsy, seizures, and similar diseases. However, it is known to have serious toxic effects on the liver and the kidney. Oxidative stress and other metabolites of VPA have been suggested to be responsible for VPA induced hepatotoxicity and nephrotoxicity. We evaluated the possible protective role of royal jelly (RJ) against the effects of VPA through toxicity tests on livers and kidneys of rats. Twenty-four male albino rats were separated into three groups; group (1): healthy control received no drug, group (2): administrated VPA (500 mg/kg/day by oral gavage), group (3): received VPA (500 mg/kg/day by oral gavage) one hour prior to RJ (500 mg/kg/day by oral gavage). After two weeks, the rats' livers and kidneys were removed for histopathologic investigation with hematoxylin and eosin staining while biochemical assessment was performed on blood samples. The VPA group had a significant increase in serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), urea, creatinine and pro-inflammatory cytokines (IL-1a, IL-1b and IL-6). Histopathological observations in liver and kidney tissues also were related with the biochemical parameters. VPA causes hepato-renal damage by promoting inflammation, oxidative stress, and fibrosis. RJ enhanced the functions of the liver and kidneys by reducing ALT, AST, urea and creatinine compared with the VPA treatment group and reduced serum pro-inflammatory cytokines. In addition, the histopathological impairment of liver and kidney tissues were reversed by RJ treatment. In conclusion, RJ can protect hepato-renal functions against VPA acid-induced organ damage.